Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057675830> ?p ?o ?g. }
- W2057675830 endingPage "1896" @default.
- W2057675830 startingPage "1894" @default.
- W2057675830 abstract "Highly active antiretroviral therapies (HAART) usually reduce the blood plasma virus load (BPVL) of HIV-1 to undetectable levels in most naïve patients within 3 months. The semen virus load (SVL) is correlated with the BPVL if HAART is effective [1–3]. But some cross-sectional studies have found differences between the BPVL and the SVL [4,5] and differences in the rates at which the virus loads in the blood and semen decrease [6]. Thus, patients on effective HAART with an undetectable BPVL may have unsuspected HIV-1 genital tract replication that could influence the long-term efficiency of HAART or result in the sexual transmission of HIV during unprotected intercourse. We describe a case of persistent HIV-1 RNA shedding into semen despite HAART-controlled BPVL. A 34-year-old untreated HIV-1-infected man presented for medically assisted procreation in February 2006. A HAART regimen was initiated in June 2006 because his SVL was greater than 4 log copies/ml in two successive samples (Table 1). His BPVL was undetectable 4 months later, but the SVL remained unchanged at 6 months. The treatment was modified in May 2007. His BPVL was still undetectable 1 month later, but the SVL remained unchanged after 6 months on the new treatment. The SVL subsequently decreased slowly to less than 400 copies/ml after 11 months on the new treatment and 22 months after initiation.Table 1: Evolution of blood plasma HIV-1 virus load, semen plasma HIV-1 virus load and semen parameters during follow-up.The resistance genotypes of the blood and seminal virus were determined in order to understand why HIV shedding into the semen persisted. The viruses in both compartments were wild-type before treatment initiation and in November 2007. Genotyping and phenotyping showed that the viruses in the same samples were R5 [7]. The patient's semen parameters were normal throughout the follow-up period. Hepatitis B virus, hepatitis C virus, syphilis and chlamydia serology remained negative and he had no reported history of other sexually transmitted infections. BPVL and SVL are usually undetectable within 1 year after treatment initiation [8]. However, this case report confirms that HAART may act at different rates in the blood and semen and that HIV-1 may continue to be shed into the semen despite effective control of HIV-1 in the blood. Treatment adherence seemed good in this case, with 10 undetectable BPVLs during the 2-year follow-up. No biological factors known to be associated with HIV-1 shedding were present, and the patient was asymptomatic, although his SVL was higher than his BPVL before treatment. The sources of the HIV-1 shed into the semen are not clear, but the lower genital tract seems to be the main one [9,10]. Known factors associated with genital shedding are urethritis [11], genital tract infections and shedding of semen polymorphonuclear cells [12]. The absence of any response to HAART during the first regimen and the retarded response to the second were probably linked to the poor penetration of the antiretroviral drugs, particularly protease inhibitors, into the male genital tract. Only the lopinavir and ritonavir concentrations could be measured in March 2008: they were 3.20 and 0.13 mg/l in the blood plasma and 0.08 and less than 0.01 mg/l in the seminal plasma, respectively. The lopinavir concentration in the semen was low, as previously reported [13,14]. By contrast, the concentrations of reverse transcriptase inhibitors in the semen are reported to be higher than in blood [15]. This rate of SVL reduction does not indicate that HAART has a direct effect on virus replication in the genital tract but that HIV-1 replication may be slowly stopped by interrupting the supply of HIV-1-infected cells from the blood. The concentrations of these drugs in the various tissues and cell types of the male genital tract are unknown. This absence of virus selection in the genital tract, despite high virus replication, indicates that the intracellular drug concentrations are too low to inhibit virus replication and to induce virus selection. Resistance mutation has been detected in genital tract viruses, and the mutation patterns are different from those of blood virus [16–19]. Nevertheless, the emergence of resistance mutations from the genital tract has never been confirmed. Furthermore, semen virus always has fewer resistance mutations. This evidence obtained from studies in a few patients does not suggest that the male genital tract is directly implicated in HAART failure. Counselling on the prevention of sexual transmission should include the possibility of occult persistent HIV-1 replication within the genital tract, particularly in the context of giving a ‘license to love’ to patients with undetectable BPVL [20]. More studies are also needed because of its possible impact on the long-term efficacy of HAART. Acknowledgements C.P. is responsible for data collection and analysis and for the writing of the manuscript. N.M., M.D. contributed to the clinical follow-up of the patient and performed semen quality testing. C.S. is responsible for HIV tropism testing. K.S. is responsible for HIV resistance testing. M.L. is responsible for antiretroviral drug concentrations measurement. J.I. contributed to data analysis and the editing of the manuscript. L.B. contributed to the clinical follow-up of the patient, data analysis and the editing of the manuscript." @default.
- W2057675830 created "2016-06-24" @default.
- W2057675830 creator A5010790026 @default.
- W2057675830 creator A5016321008 @default.
- W2057675830 creator A5043749772 @default.
- W2057675830 creator A5056738962 @default.
- W2057675830 creator A5058194563 @default.
- W2057675830 creator A5079497328 @default.
- W2057675830 creator A5080763997 @default.
- W2057675830 creator A5088261783 @default.
- W2057675830 date "2008-09-12" @default.
- W2057675830 modified "2023-10-15" @default.
- W2057675830 title "Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract" @default.
- W2057675830 cites W1964508839 @default.
- W2057675830 cites W2000318115 @default.
- W2057675830 cites W2004290526 @default.
- W2057675830 cites W2010556886 @default.
- W2057675830 cites W2019008837 @default.
- W2057675830 cites W2021829495 @default.
- W2057675830 cites W2022876489 @default.
- W2057675830 cites W2024125496 @default.
- W2057675830 cites W2031533049 @default.
- W2057675830 cites W2034085790 @default.
- W2057675830 cites W2037750075 @default.
- W2057675830 cites W2045052780 @default.
- W2057675830 cites W2056611927 @default.
- W2057675830 cites W2075141046 @default.
- W2057675830 cites W2113633275 @default.
- W2057675830 cites W2141632945 @default.
- W2057675830 cites W2162487535 @default.
- W2057675830 cites W2315102553 @default.
- W2057675830 cites W2323346400 @default.
- W2057675830 doi "https://doi.org/10.1097/qad.0b013e3283101281" @default.
- W2057675830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18753873" @default.
- W2057675830 hasPublicationYear "2008" @default.
- W2057675830 type Work @default.
- W2057675830 sameAs 2057675830 @default.
- W2057675830 citedByCount "24" @default.
- W2057675830 countsByYear W20576758302012 @default.
- W2057675830 countsByYear W20576758302014 @default.
- W2057675830 countsByYear W20576758302015 @default.
- W2057675830 countsByYear W20576758302016 @default.
- W2057675830 countsByYear W20576758302017 @default.
- W2057675830 crossrefType "journal-article" @default.
- W2057675830 hasAuthorship W2057675830A5010790026 @default.
- W2057675830 hasAuthorship W2057675830A5016321008 @default.
- W2057675830 hasAuthorship W2057675830A5043749772 @default.
- W2057675830 hasAuthorship W2057675830A5056738962 @default.
- W2057675830 hasAuthorship W2057675830A5058194563 @default.
- W2057675830 hasAuthorship W2057675830A5079497328 @default.
- W2057675830 hasAuthorship W2057675830A5080763997 @default.
- W2057675830 hasAuthorship W2057675830A5088261783 @default.
- W2057675830 hasBestOaLocation W20576758301 @default.
- W2057675830 hasConcept C126322002 @default.
- W2057675830 hasConcept C12914427 @default.
- W2057675830 hasConcept C142462285 @default.
- W2057675830 hasConcept C16685009 @default.
- W2057675830 hasConcept C197746943 @default.
- W2057675830 hasConcept C203014093 @default.
- W2057675830 hasConcept C2522874641 @default.
- W2057675830 hasConcept C2776452011 @default.
- W2057675830 hasConcept C2778093475 @default.
- W2057675830 hasConcept C2780727368 @default.
- W2057675830 hasConcept C2781413609 @default.
- W2057675830 hasConcept C3013748606 @default.
- W2057675830 hasConcept C3019340110 @default.
- W2057675830 hasConcept C42407357 @default.
- W2057675830 hasConcept C71924100 @default.
- W2057675830 hasConcept C90924648 @default.
- W2057675830 hasConceptScore W2057675830C126322002 @default.
- W2057675830 hasConceptScore W2057675830C12914427 @default.
- W2057675830 hasConceptScore W2057675830C142462285 @default.
- W2057675830 hasConceptScore W2057675830C16685009 @default.
- W2057675830 hasConceptScore W2057675830C197746943 @default.
- W2057675830 hasConceptScore W2057675830C203014093 @default.
- W2057675830 hasConceptScore W2057675830C2522874641 @default.
- W2057675830 hasConceptScore W2057675830C2776452011 @default.
- W2057675830 hasConceptScore W2057675830C2778093475 @default.
- W2057675830 hasConceptScore W2057675830C2780727368 @default.
- W2057675830 hasConceptScore W2057675830C2781413609 @default.
- W2057675830 hasConceptScore W2057675830C3013748606 @default.
- W2057675830 hasConceptScore W2057675830C3019340110 @default.
- W2057675830 hasConceptScore W2057675830C42407357 @default.
- W2057675830 hasConceptScore W2057675830C71924100 @default.
- W2057675830 hasConceptScore W2057675830C90924648 @default.
- W2057675830 hasIssue "14" @default.
- W2057675830 hasLocation W20576758301 @default.
- W2057675830 hasLocation W20576758302 @default.
- W2057675830 hasLocation W20576758303 @default.
- W2057675830 hasOpenAccess W2057675830 @default.
- W2057675830 hasPrimaryLocation W20576758301 @default.
- W2057675830 hasRelatedWork W2416583051 @default.
- W2057675830 hasRelatedWork W2587999459 @default.
- W2057675830 hasRelatedWork W3028391595 @default.
- W2057675830 hasRelatedWork W3045863127 @default.
- W2057675830 hasRelatedWork W3090012918 @default.
- W2057675830 hasRelatedWork W3120212630 @default.
- W2057675830 hasRelatedWork W3207308314 @default.